Anthera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

ANTH 4.93 +0.19 (4.01%)
price chart
Anthera Pharmaceuticals Inc (ANTH): Another Cash-Poor, Bubbly Biotech About ...
Anthera Pharmaceuticals Inc (NASDAQ:ANTH) investors may have forgotten its 2013 drug study scandal that set the scientific community spinning, as well as the Nasdaq delisting that it barely dodged again last month.
Technical Coverage on Biotech Stocks -- Anthera Pharma, RXi Pharma, MiMedx ...  Virtual Press Office (press release)
Anthera Pharmaceuticals Raised to Neutral at Citigroup Inc. (ANTH)
Anthera Pharmaceuticals logo Anthera Pharmaceuticals (NASDAQ:ANTH) was upgraded by research analysts at Citigroup Inc. from a “sell” rating to a “neutral” rating in a report released on Tuesday, TheFlyOnTheWall.com reports. Shares of Anthera ...
Anthera Pharmaceuticals Reports 2015 First Quarter and Operational Update  Nasdaq
Anthera Pharmaceuticals Stock Rating Upgraded by Citigroup Inc. (ANTH)
Anthera Pharmaceuticals logo Anthera Pharmaceuticals (NASDAQ:ANTH) was upgraded by Citigroup Inc. to a “neutral” rating in a research note issued on Wednesday.
Anthera Pharmaceuticals Upgraded to "Neutral" at Citigroup Inc. (ANTH)  Mideast Time
Shining on Major News: Giga-tronics Inc. (NASDAQ:GIGA), Yamana Gold, Inc ...  Stock Transcript
Anthera Pharmaceuticals Lifted to Neutral at Citigroup Inc. (ANTH)
Anthera Pharmaceuticals Inc logo Citigroup Inc. upgraded shares of Anthera Pharmaceuticals (NASDAQ:ANTH) to a neutral rating in a research report sent to investors on Wednesday morning.
Hot News: Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), Halcon Resources ...  Stock Transcript
Anthera Pharmaceuticals Rating Increased to Neutral at Citigroup Inc. (ANTH)
Anthera Pharmaceuticals logo Anthera Pharmaceuticals (NASDAQ:ANTH) was upgraded by equities researchers at Citigroup Inc. to a “neutral” rating in a research report issued on Wednesday. Anthera Pharmaceuticals (NASDAQ:ANTH) opened at 4.85 on ...
Drowning Stocks Update - Anthera Pharmaceuticals Inc (NASDAQ:ANTH ...
On Monday, Following U.S. Stocks were among the “Top Losers”: Anthera Pharmaceuticals Inc (NASDAQ:ANTH), NTELOS Holdings Corp (NASDAQ:NTLS), Axion Power International, Inc. (NASDAQ:AXPW), Seventy Seven Energy Inc (NYSE:SSE).
Gigantic Turns Alert - Insmed Incorporated (NASDAQ:INSM), Anthera ...
Anthera Pharmaceuticals Inc (NASDAQ:ANTH), raised 6.96%, and closed at $5.53, hitting new 52-week high of $5.61. The stock has the beta value of 1.77, and its volatility for the week is 7.55%, while for the month it is 11.07%.
Anthera Pharmaceuticals Upgraded at Citigroup Inc. (ANTH)
Anthera Pharmaceuticals Inc logo Citigroup Inc. upgraded shares of Anthera Pharmaceuticals (NASDAQ:ANTH) from a sell rating to a neutral rating in a report issued on Tuesday, TheFlyOnTheWall.
Big Movers: Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), TheStreet, Inc ...  Stock Transcript
Mid-Day Changers: Anthera Pharmaceuticals, Inc. (ANTH), Liberator Medical ...  WallStreet Scope
Today's Morning Insights: Oil States International Inc. (OIS), Anthera ...
Anthera Pharmaceuticals, Inc. (ANTH) of the Biotechnology sector closed out the day Friday at $4.74, a loss of -0.21% trading at a volume of 283,998 shares.
Analysis On Gaining Stocks: MannKind Corporation (NASDAQ:MNKD), Anthera ...
Anthera Pharmaceuticals Inc (NASDAQ:ANTH), raised 4.99%, and closed at $5.47. The stock has the beta value of 1.77, and its volatility for the week is 14.72%, while for the month it is 13.06%.